BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11823974)

  • 1. MUC1 mucin and trefoil factor 1 protein expression in renal cell carcinoma: correlation with prognosis.
    Kraus S; Abel PD; Nachtmann C; Linsenmann HJ; Weidner W; Stamp GW; Chaudhary KS; Mitchell SE; Franke FE; Lalani el-N
    Hum Pathol; 2002 Jan; 33(1):60-7. PubMed ID: 11823974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression and clinical relevance of MUC1 in renal cell carcinoma metastasis.
    Rausch S; Beermann J; Scharpf M; Hennenlotter J; Fend F; Stenzl A; Schollenberger D; Bedke J; Kruck S
    World J Urol; 2016 Dec; 34(12):1635-1641. PubMed ID: 26995391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of MUC1 mucins inversely correlated with post-surgical survival of renal cell carcinoma patients.
    Fujita K; Denda K; Yamamoto M; Matsumoto T; Fujime M; Irimura T
    Br J Cancer; 1999 Apr; 80(1-2):301-8. PubMed ID: 10390012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUC1 expression is correlated with nuclear grade and tumor progression in pT1 renal clear cell carcinoma.
    Leroy X; Zerimech F; Zini L; Copin MC; Buisine MP; Gosselin B; Aubert JP; Porchet N
    Am J Clin Pathol; 2002 Jul; 118(1):47-51. PubMed ID: 12109855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of MUC1, Thomsen-Friedenreich-related antigens, and cytokeratin 19 in human renal cell carcinomas and tubular clear cell lesions.
    Cao Y; Karsten U; Zerban H; Bannasch P
    Virchows Arch; 2000 Feb; 436(2):119-26. PubMed ID: 10755601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of fully and under-glycosylated forms of MUC1 mucin in gastric carcinoma.
    Reis CA; David L; Seixas M; Burchell J; Sobrinho-Simões M
    Int J Cancer; 1998 Aug; 79(4):402-10. PubMed ID: 9699534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic value of morphologic subdivision of papillary renal cell carcinoma and MUC1 expression].
    Blel A; Kourda N; Baltagi Ben Jilani S; Zermani R
    Prog Urol; 2008 Oct; 18(9):575-9. PubMed ID: 18986629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases.
    Langner C; Ratschek M; Rehak P; Schips L; Zigeuner R
    Mod Pathol; 2004 Feb; 17(2):180-8. PubMed ID: 14657952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic expression of CD133 stemness marker is associated with tumor aggressiveness in clear cell renal cell carcinoma.
    Saeednejad Zanjani L; Madjd Z; Abolhasani M; Andersson Y; Rasti A; Shariftabrizi A; Asgari M
    Exp Mol Pathol; 2017 Oct; 103(2):218-228. PubMed ID: 29050853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of MUC1 and sialyl Lewis antigens in different areas of clear renal cell carcinoma.
    Borzym-Kluczyk M; Radziejewska I; Cechowska-Pasko M
    Clin Exp Nephrol; 2015 Aug; 19(4):732-7. PubMed ID: 25091456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphologic subtyping of papillary renal cell carcinoma: correlation with prognosis and differential expression of MUC1 between the two subtypes.
    Leroy X; Zini L; Leteurtre E; Zerimech F; Porchet N; Aubert JP; Gosselin B; Copin MC
    Mod Pathol; 2002 Nov; 15(11):1126-30. PubMed ID: 12429790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up.
    Minardi D; Lucarini G; Filosa A; Milanese G; Zizzi A; Di Primio R; Montironi R; Muzzonigro G
    Int J Immunopathol Pharmacol; 2008; 21(2):447-55. PubMed ID: 18547492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC1 immunoexpression is a virtually constant feature of clear cell renal cell carcinoma metastatic to the pancreas.
    Pająk J; Liszka L; Mrowiec S; Gołka D; Lampe P
    Adv Anat Pathol; 2012 Mar; 19(2):125-7. PubMed ID: 22313840
    [No Abstract]   [Full Text] [Related]  

  • 14. HDAC6 serves as a biomarker for the prognosis of patients with renal cell carcinoma.
    Zhang Z; Cao Y; Zhao W; Guo L; Liu W
    Cancer Biomark; 2017; 19(2):169-175. PubMed ID: 28128740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma.
    Rasti A; Madjd Z; Abolhasani M; Mehrazma M; Janani L; Saeednejad Zanjani L; Asgari M
    Clin Exp Med; 2018 May; 18(2):177-190. PubMed ID: 29204790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis.
    Baldus SE; Mönig SP; Huxel S; Landsberg S; Hanisch FG; Engelmann K; Schneider PM; Thiele J; Hölscher AH; Dienes HP
    Clin Cancer Res; 2004 Apr; 10(8):2790-6. PubMed ID: 15102686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder.
    Kawamoto T; Shoda J; Irimura T; Miyahara N; Furukawa M; Ueda T; Asano T; Kano M; Koike N; Fukao K; Tanaka N; Todoroki T
    Clin Cancer Res; 2001 May; 7(5):1333-42. PubMed ID: 11350903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
    Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP
    Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas.
    Baldus SE; Zirbes TK; Engel S; Hanisch FG; Mönig SP; Lorenzen J; Glossmann J; Fromm S; Thiele J; Pichlmaier H; Dienes HP
    Int J Cancer; 1998 Apr; 79(2):133-8. PubMed ID: 9583726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
    Rodins K; Cheale M; Coleman N; Fox SB
    Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.